Filter Results:
(139)
Show Results For
- All HBS Web (139)
- Faculty Publications (32)
Show Results For
- All HBS Web (139)
- Faculty Publications (32)
←
Page 7 of 139
Results
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 01 Jun 2018
- News
Up by the Roots
regulated industry containing a number of distinct verticals, from capital markets to asset management and lending. Few cities on earth can boast a talent pool with quite as much relevant domain expertise as New York, which is exactly why... View Details
- 01 Jun 2018
- News
June 2018 Alumni and Faculty Books
damaged the US’s social psyche, as did widespread drug use and chemical dependency. Vivid pictures of violence in Vietnam on TV plus incessant riots in major US cities began to blur the differences between crime, punishment, and... View Details
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 21 Apr 2009
- First Look
First Look: April 21, 2009
Industry Location Author:Arthur A. Daemmrich Abstract A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a... View Details
Keywords: Martha Lagace
- 03 Jan 2017
- First Look
January 3, 2017
to standardize their products and helped establish brand identities through consistent appearance. By 1938, food dyes had achieved such widespread use, and had raised such public concern, that the federal government amended the 1906 Pure Food and View Details
Keywords: Carmen Nobel
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 01 Dec 2013
- News
Curing Health Care
Massachusetts Governor Deval Patrick joked in his speech.) Related Links A Blueprint for Patient-Driven Drug Development Gene Williams (MBA 1987) Blavatnik Gift Accelerates Biomedical Advances Oscar Winners Even worse is what... View Details
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
The book Capitalism at Risk first appeared in 2011. The problems it identified with social inequality, global trade strife, and environmental degradation have only accelerated by 2020. The new edition of Capitalism at Risk, subtitled How Business Can Lead, is expanded... View Details
Keywords: by Martha Lagace
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive abilities. “We believe it can identify harmful aggregates in the... View Details
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
Effectiveness By: Kim, Tami, Kate Barasz, and Leslie K. John Abstract—Given the increasingly specific ways marketers can target ads, many consumers and regulators are demanding ad transparency: disclosure of how consumers’ personal... View Details
Keywords: Sean Silverthorne
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details
- Web
Past Issues - Alumni
leave our jobs behind and who do we become? After Ozempic How a game-changing drug is reshaping Novo Nordisk, disrupting the pharma industry, and setting up a once-in-a-generation windfall for philanthropy Complete Table of Contents... View Details
- Web
2025 Reunion Presentations - Alumni
will regulators or other stakeholders need to play a more significant role to address a growing range of harms? Participants will leave with an understanding of how the business model creates challenges at scale and a greater sense of... View Details
- Web
Print View - Course Catalog
Destructive Sides of Early U.S. Capitalism (c. 1790-1870) Scale and the Emergence of Organization (c. 1870-1920) Prosperity, Depression and War (c. 1920-1945) Innovation, Finance and Regulation (c. 1950-2008) The American Dream (c. 1790... View Details
- ←
- 7